RCA
BIIB icon

Roberts Capital Advisors’s Biogen BIIB Stock Holding History

Roberts Capital Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-438
Closed -$84.9K – 82
2024
Q3 		$84.9K Hold
438
– – 0.07% 88
2024
Q2 		$94.4K Hold
438
– – 0.09% 89
2024
Q1 		$94.4K Buy
+438
New +$103K 0.09% 89
2022
Q3 		$125K Hold
470
– – 0.18% 88
2022
Q2 		$96K Hold
470
– – 0.13% 88
2022
Q1 		$99K Hold
470
– – 0.1% 96
2021
Q4 		$113K Buy
+470
New +$121K 0.11% 95

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Roberts Capital Advisors's BIIB Position: Q4 2024 in Review

Roberts Capital Advisors sold out of Biogen (BIIB) in Q4 2024, closing a stake of 438 shares — an estimated $84.9K sold.

Roberts Capital Advisors first reported a position in BIIB in Q4 2021 and held it in 7 quarters. The position peaked at $125K in Q3 2022. 876 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.

  • Roberts Capital Advisors reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
  • Roberts Capital Advisors sold 438 Biogen shares in Q4 2024, an estimated $84.9K.
  • Roberts Capital Advisors first reported a position in Biogen in Q4 2021 and held it in 7 quarters.
  • Roberts Capital Advisors's Biogen position peaked at $125K in Q3 2022.
  • 876 funds tracked by Wall St. Rank held Biogen as of Q4 2024.

Based on Roberts Capital Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.